1.
Bernardo M, Azanza JR, Rubio-Terrés C, Rejas J. Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the ZEUS longitudinal study Ziprasidone Extended Use in Schizphrenia (ZEUS). Actas Esp Psiquiatr [Internet]. 2007 Jul. 1 [cited 2025 Jun. 5];35(4):259-62. Available from: https://actaspsiquiatria.es/index.php/actas/article/view/882